P3 Health Partners EBITDA 2020-2025 | PIII

P3 Health Partners ebitda from 2020 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
P3 Health Partners Annual EBITDA
(Millions of US $)
2024 $-235
2023 $-81
2022 $-158
2021 $-177
2020 $-28
2019 $-39
P3 Health Partners Quarterly EBITDA
(Millions of US $)
2025-06-30 $-13
2025-03-31 $-17
2024-12-31 $-117
2024-09-30 $-85
2024-06-30 $-10
2024-03-31 $-22
2023-12-31 $-43
2023-09-30 $-12
2023-06-30 $1
2023-03-31 $-27
2022-12-31 $-51
2022-09-30 $-38
2022-06-30 $-39
2022-03-31 $-30
2021-12-31 $-113
2021-09-30 $-27
2021-06-30 $-25
2021-03-31 $-12
2020-12-31
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.052B $1.500B
P3 Health Partners is a patient-centered and physician-led population health management company. P3 Health Partners, formerly known as Foresight Acquisition Corp., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.466B 59.12
Tempus AI (TEM) United States $12.696B 0.00
Doximity (DOCS) United States $11.914B 53.01
Hims & Hers Health (HIMS) United States $9.534B 78.11
IRhythm Technologies (IRTC) United States $5.093B 0.00
Hinge Health (HNGE) United States $4.374B 0.00
Inspire Medical Systems (INSP) United States $2.663B 39.16
Privia Health (PRVA) United States $2.603B 192.82
Heartflow (HTFL) $2.489B 0.00
Enovis (ENOV) United States $1.740B 9.20
Phreesia (PHR) United States $1.681B 0.00
10x Genomics (TXG) United States $1.669B 0.00
Omnicell (OMCL) United States $1.466B 28.24
Schrodinger (SDGR) United States $1.428B 0.00
Azenta (AZTA) United States $1.388B 60.58
Clover Health Investments (CLOV) United States $1.292B 0.00
Claritev (CTEV) United States $1.115B 0.00
Evolent Health (EVH) United States $1.057B 0.00
Fulgent Genetics (FLGT) United States $0.660B 0.00
Zepp Health (ZEPP) Netherlands $0.568B 0.00
Veradigm (MDRX) United States $0.520B 0.00
Standard BioTools (LAB) United States $0.485B 0.00
Talkspace (TALK) United States $0.430B 128.50
Butterfly Network (BFLY) United States $0.347B 0.00
Carlsmed (CARL) $0.333B 0.00
TruBridge (TBRG) United States $0.293B 51.40
SOPHiA GENETICS SA (SOPH) Switzerland $0.237B 0.00
Outset Medical (OM) United States $0.237B 0.00
Nyxoah SA (NYXH) Belgium $0.214B 0.00
Health Catalyst (HCAT) United States $0.211B 0.00
KORU Medical Systems (KRMD) United States $0.190B 0.00
CapsoVision (CV) United States $0.182B 0.00
MDxHealth SA (MDXH) Belgium $0.137B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.119B 0.00
CareCloud (CCLD) United States $0.115B 5.23
American Well (AMWL) United States $0.115B 0.00
EUDA Health Holdings (EUDA) Singapore $0.086B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.074B 0.00
Pulmonx (LUNG) United States $0.062B 0.00
111 (YI) China $0.061B 0.00
HeartBeam (BEAT) United States $0.038B 0.00
Zhongchao (ZCMD) China $0.024B 0.00
Precipio (PRPO) United States $0.023B 0.00
Healthcare Triangle (HCTI) United States $0.018B 0.00
Bullfrog AI Holdings (BFRG) United States $0.013B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Movano (MOVE) United States $0.004B 0.00
MSP Recovery (MSPR) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
PROFUSA (PFSA) United States $0.003B 0.00